90 related articles for article (PubMed ID: 9129126)
1. Metabolic stimulation of mouse spleen lymphocytes by low doses of delta9-tetrahydrocannabinol.
Sánchez C; Velasco G; Guzmán M
Life Sci; 1997; 60(19):1709-17. PubMed ID: 9129126
[TBL] [Abstract][Full Text] [Related]
2. Delta9-tetrahydrocannabinol stimulates glucose utilization in C6 glioma cells.
Sánchez C; Velasco G; Guzmán M
Brain Res; 1997 Aug; 767(1):64-71. PubMed ID: 9365016
[TBL] [Abstract][Full Text] [Related]
3. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes.
Sánchez C; Galve-Roperh I; Rueda D; Guzmán M
Mol Pharmacol; 1998 Nov; 54(5):834-43. PubMed ID: 9804618
[TBL] [Abstract][Full Text] [Related]
4. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme.
Blázquez C; Sánchez C; Daza A; Galve-Roperh I; Guzmán M
J Neurochem; 1999 Apr; 72(4):1759-68. PubMed ID: 10098887
[TBL] [Abstract][Full Text] [Related]
5. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells.
Di Toro R; Campana G; Sciarretta V; Murari G; Spampinato S
Life Sci; 1998; 63(14):PL197-204. PubMed ID: 9771917
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
Carta G; Nava F; Gessa GL
Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
[TBL] [Abstract][Full Text] [Related]
7. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
Freedland CS; Whitlow CT; Miller MD; Porrino LJ
Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation.
Koh WS; Crawford RB; Kaminski NE
Biochem Pharmacol; 1997 May; 53(10):1477-84. PubMed ID: 9260875
[TBL] [Abstract][Full Text] [Related]
10. (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase.
Bayewitch M; Rhee MH; Avidor-Reiss T; Breuer A; Mechoulam R; Vogel Z
J Biol Chem; 1996 Apr; 271(17):9902-5. PubMed ID: 8626625
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptors and the cytokine network.
Klein TW; Newton C; Friedman H
Adv Exp Med Biol; 1998; 437():215-22. PubMed ID: 9666274
[TBL] [Abstract][Full Text] [Related]
12. Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action.
Ko MC; Woods JH
Psychopharmacology (Berl); 1999 Apr; 143(3):322-6. PubMed ID: 10353438
[TBL] [Abstract][Full Text] [Related]
13. delta(9)-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1.
Velasco L; Ruiz L; Sánchez MG; Díaz-Laviada I
Eur J Biochem; 2001 Feb; 268(3):531-5. PubMed ID: 11168391
[TBL] [Abstract][Full Text] [Related]
14. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].
Shivachar AC; Martin BR; Ellis EF
Biochem Pharmacol; 1996 Mar; 51(5):669-76. PubMed ID: 8615904
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid ligand-receptor signaling in the mouse uterus.
Das SK; Paria BC; Chakraborty I; Dey SK
Proc Natl Acad Sci U S A; 1995 May; 92(10):4332-6. PubMed ID: 7753807
[TBL] [Abstract][Full Text] [Related]
16. Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.
Petitet F; Jeantaud B; Reibaud M; Imperato A; Dubroeucq MC
Life Sci; 1998; 63(1):PL1-6. PubMed ID: 9667767
[TBL] [Abstract][Full Text] [Related]
17. Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.
Sánchez C; Galve-Roperh I; Canova C; Brachet P; Guzmán M
FEBS Lett; 1998 Sep; 436(1):6-10. PubMed ID: 9771884
[TBL] [Abstract][Full Text] [Related]
18. Suppression of lymphocyte adenosine 3':5'-cyclic monophosphate (cAMP) by delta-9-tetrahydrocannabinol.
Diaz S; Specter S; Coffey RG
Int J Immunopharmacol; 1993 May; 15(4):523-32. PubMed ID: 8396073
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids enhance human B-cell growth at low nanomolar concentrations.
Derocq JM; Ségui M; Marchand J; Le Fur G; Casellas P
FEBS Lett; 1995 Aug; 369(2-3):177-82. PubMed ID: 7544292
[TBL] [Abstract][Full Text] [Related]
20. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
Dhawan K; Kumar S; Sharma A
J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
